Pfizer (PFE) Income from Non-Controlling Interests (2009 - 2026)

Pfizer (PFE) has 18 years of Income from Non-Controlling Interests data on file, last reported at $8.0 million in Q1 2026.

• Income from Non-Controlling Interests for Q1 2026 came in at $8.0 million, up 33.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $43.0 million (up 48.28% YoY), and the FY2025 annual result was $41.0 million, up 32.26% from the prior year.
• Income from Non-Controlling Interests steadied at $8.0 million in Q1 2026 per PFE's latest filing, from $8.0 million in the prior quarter.
• Over five years, Income from Non-Controlling Interests peaked at $18.0 million in Q2 2025 and troughed at $6.0 million in Q2 2022.
• A 5-year average of $9.2 million and a median of $8.0 million in 2024 frame the typical range for Income from Non-Controlling Interests.
• The sharpest annual moves came in 2022 and 2025: Income from Non-Controlling Interests sank 76.92% in 2022, then jumped 157.14% in 2025.
• A 5-year view of Income from Non-Controlling Interests shows it stood at $15.0 million in 2022, then plunged by 40.0% to $9.0 million in 2023, then fell by 11.11% to $8.0 million in 2024, then changed by 0.0% to $8.0 million in 2025, then changed by 0.0% to $8.0 million in 2026.
• Business Quant data shows PFE's Income from Non-Controlling Interests at $8.0 million in Q1 2026, $8.0 million in Q4 2025, and $9.0 million in Q3 2025.